About the Study:
Many people who get COVID-19 have mild or moderate symptoms like coughing, a fever, and shortness of breath. But some also get severe pneumonia in both lungs. COVID-19 with pneumonia is a serious illness that can be deadly.
Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. Pneumonia can range in seriousness from mild to life-threatening. It is most serious for infants and young children, people older than age 65, and people with health problems or weakened immune systems.
Anyone can get COVID-19 and pneumonia, but it’s more likely in people who are 65 or older. Those who are 85 or older are at the highest risk.
Rochester Clinical Research is seeking volunteers 50 years old and up for a study to evaluate the safety and effectiveness of a combination pneumococcal and COVID vaccine.
This study will compare Pneumovax or Vaxneuvance, both FDA approved pneumonia vaccines, to a Moderna mRNA COVID Vaccine which is EUA approved by the FDA.
All volunteers in this study are guaranteed both a Pneumonia vaccine and Moderna COVID booster.
This trial will last approximately 6 months with 3 visits to our office and 3 telephone calls.
Study-related care is available to participants at no cost and health insurance is not required nor needed.
Compensation up to $200 per in-office visit for time and travel is available to those who qualify.
- Be 50 years of age or older
- Received both doses of Moderna COVID vaccine over 6 months ago
- Have not previously received a COVID vaccine booster
- Have not previously received a Pneumonia Vaccine
- Have not previously been diagnosed with COVID-19
- Please note, other conditions do apply